Advertisement

Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol)

      Abstract

      Patients with congestive heart failure (CHF) exhibit a decrease in maximal exercise capacity in response to a cold environment. The aim of this study was to further investigate the impact of cold exposure on submaximal exercise capacity, systemic adrenergic drive, and the effects of long-term β-adrenergic blockade on these parameters. Thirty-three patients with CHF, with exercise limited by dyspnea and left ventricular ejection fraction of 26 ± 4%, were randomized to receive metoprolol or carvedilol for 6 months. The observations were compared with 12 age-matched healthy volunteers. Maximal exercise performance with gas exchange analyses were assessed using a ramp protocol, and endurance capacity was measured using 2 constant-load exercise tests performed randomly at 20°C and −8°C. Healthy volunteers increased their submaximal exercise time by 20% (1,353 ± 455 [20°C] vs 1,635 ± 475 seconds [−8°C]; p <0.05), whereas patients with CHF exhibited a 21% decrease in exercise time (1,182 ± 549 [20°C] vs 931 ± 524 seconds [−8°C]; p <0.05) at −8°C. Beta blockers increased submaximal exercise duration at 20°C (+261 ± 617 seconds; p <0.05) and −8°C (+374 ± 729 seconds; p <0.05). Norepinephrine increased to a greater extent at 4 minutes and at the time of exhaustion (at −8°C) only in patients with CHF. Beta-adrenergic blockade caused no significant decrease in plasma norepinephrine levels. Patients with symptomatic CHF exhibited a significant decrease in submaximal exercise time in response to moderate cold exposure. Beta-blocker therapy with either metoprolol or carvedilol significantly increases submaximal exercise time and attenuates the impact of cold exposure on functional capacity.
      To read this article in full you will need to make a payment

      References

        • Juneau M.
        • Larivée L.
        • White M.
        Cold temperature impairs maximal exercise performance in patients with heart failure.
        Can J Cardiol. 2002; 18: 981-986
        • Sponer G.
        • Bartsch W.
        • Strein K.
        • Muller-Beckmann B.
        • Bohm E.
        Pharmacological profile of carvedilol as a β-blocking agent with vasodilating and hypotensive properties.
        J Cardiovasc Pharmacol. 1987; 9: 317-327
        • Myers J.
        • Buchanan N.
        • Walsh D.
        • Kraemer M.
        • McAuley P.
        • Hamilton-Wessler M.
        • Froelicher V.F.
        Comparison of the ramp versus standard exercise protocols.
        J Am Coll Cardiol. 1991; 17: 1334-1342
        • Wasserman K.
        • Hansen J.E.
        • Sue D.Y.
        • Casaburi R.
        • Whipp B.J.
        Measurements during integrative cardiopulmonary exercise testing.
        in: Weinberg R. Principles of Exercise Testing and Interpretation. Lippincott Williams & Wilkins, Baltimore, MD1999: 74-77
        • Leon D.F.
        • Amidi M.
        • Leonard J.J.
        Left heart work and temperature responses to cold exposure in man.
        Am J Cardiol. 1970; 26: 38-45
        • Hayward J.M.
        • Holmes W.F.
        • Gooden B.A.
        Cardiovascular responses in man to a stream of cold air.
        Cardiovasc Res. 1976; 10: 691-696
        • Epstein S.E.
        • Stampfer M.
        • Beiser G.D.
        • Goldstein R.E.
        • Braunwald E.
        Effects of a reduction in environmental temperature on the circulatory response to exercise in man.
        N Engl J Med. 1969; 280: 7-11
        • Marchant B.
        • Donaldson G.
        • Mridha K.
        • Scarborough M.
        • Timmis A.D.
        Mechanisms of cold intolerance in patients with angina.
        J Am Coll Cardiol. 1994; 23: 630-636
        • Juneau M.
        • Johnstone M.
        • Dempsey E.
        • Waters D.D.
        Exercise-induced myocardial ischemia in a cold environment. Effect of antianginal medications.
        Circulation. 1989; 79: 1015-1020
        • Walsh J.T.
        • Andrews R.
        • Batin P.D.
        • Cowley A.J.
        Haemodynamic and hormonal response to a stream of cooled air.
        Eur J Appl Physiol. 1995; 72: 76-80
        • Arnett E.L.
        • Watts D.T.
        Catecholamine excretion in men exposed to cold.
        J Appl Physiol. 1960; 15: 499-500
        • MERIT-HF Study Group
        Effect of metoprolol CR/XL in chronic heart failure.
        Lancet. 1999; 353: 2001-2007
        • Australia/New Zealand Heart Failure Research Collaborative Group
        Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease.
        Lancet. 1997; 349: 375-380
        • Gilbert E.M.
        • Abraham W.T.
        • Olsen S.
        • Hattler B.
        • White M.
        • Mealy P.
        • Larrabee P.
        • Bristow M.R.
        Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
        Circulation. 1996; 94: 2817-2825
        • Gullestad L.
        • Manhenke C.
        • Aarsland T.
        • Skardal R.
        • Fagertun H.
        • Wikstrand J.
        • Kjekshus J.
        Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure—a substudy to the MERIT-HF trial.
        Eur J Heart Failure. 2001; 3: 463-468
        • Bristow M.R.
        • Gilbert E.M.
        • Abraham W.T.
        • Adams K.F.
        • Fowler M.B.
        • Hershberger R.E.
        • Kubo S.H.
        • Narahara K.A.
        • Ingersoll H.
        • Krueger S.
        • Young S.
        • Shusterman N.
        Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure (MOCHA).
        Circulation. 1996; 94: 2807-2816
        • Metra M.
        • Nodari S.
        • Raccagni D.
        • Garbellini M.
        • Boldi E.
        • Bontempi L.
        • Gaiti M.
        • Dei Cas L.
        Maximal and submaximal exercise testing in heart failure.
        J Cardiovasc Pharmacol. 1998; 32: S36-S45
        • Metra M.
        • Nardi M.
        • Giubbini R.
        • Dei Cas L.
        Effects of short- and long-term carvedilol adminstration on rest and exercise heamodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
        J Am Coll Cardiol. 1994; 24: 1678-1687
        • Andersson B.
        • Hamm C.
        • Persson S.
        • Wikstrom G.
        • Sinagra G.
        • Hjalmarson A.
        • Waagstein F.
        Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment.
        J Am Coll Cardiol. 1994; 23: 1397-1404
        • Eichhorn E.J.
        • Bedotto J.B.
        • Malloy C.R.
        • Hatfield B.A.
        • Deitchman D.
        • Brown M.
        • Willard J.E.
        • Grayburn P.A.
        Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure.
        Circulation. 1990; 82: 473-483
        • Kaye D.M.
        • Lefkovits J.
        • Jennings G.L.
        • Bergin P.
        • Broughton A.
        • Esler M.D.
        Adverse consequences of high sympathetic nervous activity in the failing human heart.
        J Am Coll Cardiol. 1995; 26: 1257-1263